癌痛示范病房创建前后麻醉性镇痛药物临床应用的变化

Change of Clinical Application of Narcotic Analgesic Drugs before and after Establishing the Cancer Pain Demonstration Ward

目的调查癌痛规范化治疗示范病房(以下简称癌痛示范病房)创建前后麻醉性镇痛药物在癌痛患者中的应用情况。方法统计分析2014年1月至6月和2015年1月至6月住院患者麻醉性镇痛药物用量及用药频度。结果 2015年1月至6月与2014年1月至6月相比,癌痛患者的麻醉药品应用呈逐渐递增趋势,盐酸羟考酮缓释片成为首选药物。结论成立癌痛示范病房后,规范了麻醉性镇痛药物在癌痛治疗方面的应用。

Objective To investigate the application of narcotic analgesic drugs in cancer patients before and after the establishment of the standardized cancer pain treatment demonstration ward（ hereinafter referred to as the cancer pain management ward）. Methods The consumption amount and DDDs of narcotic analgesics in the inpatient during January to June in 2014 and January to June in 2015 collected from hospital information system were analyzed. Results Compared with the situation during January to June in 2014,the amount of application of narcotic analgesic drugs during January to June in 2014 was gradually increasing; The controlled- release oxycodone turned out to be the preferred drug. Conclusion After the establishment of the pain management ward,the application of the narcotic analgesic drugs in treating the cancer pain is normalized.